Bradlee Heckmann

Bradlee Heckmann

Company: Asha Therapeutics & USF Health Neuroscience Institute

Job title: Chief Scientific Officer & Asst. Professor

Seminars:

From Inflammasome to Mitochondria, Novel Therapies for Neurodegenerative Diseases 2:00 pm

Inflammasome activation is a key drive of pathology in multiple neurodegenerative diseases Targeting both inflammasomes and mitochondria prove efficacious in reducing pathology in multiple murine disease models. We have developed a novel, brain-penetrant inhibitor of mitochondrial fragmentation that limits inflammation and reduces Parkinson’s Disease pathologyRead more

day: Day 1 - Track B - Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.